InTandem Capital Partners, LLC (“InTandem Capital”), a healthcare services focused private equity firm, announced today that its affiliated funds, InTandem Capital Partners Fund II, LP and InTandem Capital Opportunities Fund, LP, have completed a majority recapitalization and combination of MPP Infusion Centers and ID Consultants, both leading providers of accessible and affordable ambulatory infusion services. The two companies will combine to create Vivo Infusion. Based in Denver, Colorado, Vivo Infusion is a provider of accessible, affordable, and safe community-based infusion and injection care for patients suffering from compromised immune systems, infectious disease, and other medical conditions.
Read the full article: InTandem Capital Partners Announces Creation of Vivo Infusion by Combining MPP Infusion Centers and ID Consultants //
Source: https://www.businesswire.com/news/home/20220310005090/en/InTandem-Capital-Partners-Announces-Creation-of-Vivo-Infusion-by-Combining-MPP-Infusion-Centers-and-ID-Consultants
